Evidence map›Paper›PMID 41088362›Full record

ArticleCell communication and signaling : CCS2025

Enabling mechanistic studies of EVs in vivo: a protocol for isolation and cell-specific labelling in larval zebrafish.

Ezgi Kiyga, Katy Reid, Guillaume van Niel, Julie Mazzolini, Dirk Sieger

Abstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ezgi KiygaInstitute for Neuroscience and Cardiovascular Research, University of Edinburgh, 49 Little France Crescent, Edinburgh, EH16 4SB, UK.ORCID http://orcid.org/0000-0002-1325-8268
Katy ReidUK Dementia Research Institute, University of Edinburgh, 49 Little France Crescent, Edinburgh, EH16 4SB, UK.
Guillaume van NielCRCI2NA, Nantes Université, INSERM UMR1307, CNRS UMR6075, Université d'Angers, Nantes, France.ORCID http://orcid.org/0000-0002-8651-9705
Julie MazzoliniInstitute for Neuroscience and Cardiovascular Research, University of Edinburgh, 49 Little France Crescent, Edinburgh, EH16 4SB, UK. Julie.Mazzolini@ed.ac.uk.ORCID http://orcid.org/0000-0001-9347-5635
Dirk SiegerInstitute for Neuroscience and Cardiovascular Research, University of Edinburgh, 49 Little France Crescent, Edinburgh, EH16 4SB, UK. dirk.sieger@ed.ac.uk.ORCID http://orcid.org/0000-0001-6881-5183

Funding

Brain Research UK 202122-36Wellcome Trust
6 · The paper itself

Abstract

backgroundExtracellular vesicles (EVs) are critical mediators of intercellular communication in development, physiology, and disease. In vivo models such as Drosophila melanogaster, Caenorhabditis elegans, and Danio rerio (zebrafish) now provide powerful platforms to visualize EV dynamics in real time. However, the full potential of these models remains underutilized due to the lack of reliable, cell-specific EV labelling tools and robust EV isolation protocols. Here, we present an optimized workflow for the isolation of EVs from zebrafish larvae and the in vivo labelling of EVs in a cell-type-specific manner.

methodsTo isolate EVs from larval zebrafish, we used size exclusion chromatography (SEC). By comparing different tissue digestion methods and performing step-by-step optimisation of sample preparation prior to SEC, we established a novel protocol that enables EV isolation without compromising cell viability. EV size and concentration were assessed by nanoparticle tracking analysis (NTA), with subsequent characterization by transmission electron microscopy (TEM) and Western blotting. To evaluate the sensitivity of our protocol, we treated zebrafish larvae with GW4869, a known inhibitor of EV biogenesis, and assessed the dose-dependent effects on EV release. To specifically label EVs from distinct cell types, we have generated a UAS: CD63-GFP construct which can be expressed under control of the Gal4 transcriptional activator.

resultsThrough a systematic comparison of tissue dissociation techniques, we identify Bacillus licheniformis protease as a superior alternative to conventional collagenase treatment, which compromises cell integrity. Treatment with GW4869 confirmed that EV biogenesis and release can be inhibited in a dose-dependent manner and demonstrated that our protocol is sensitive enough to detect and quantify changes in EV levels. To enable cell-specific EV tracking in vivo, we combined the UAS: CD63-GFP construct with a radial glia-specific Gal4 driver line, providing a proof-of-concept for targeted EV imaging in intact tissues.

conclusionsThese advances provide a versatile toolkit for mechanistic studies of EV function in vivo. The broad availability of cell-type-specific Gal4 driver lines in zebrafish and Drosophila will now allow researchers to trace EV dynamics from virtually any cell type, while our isolation protocol enables rigorous, quantitative EV analyses across developmental and pathological contexts.

Indexed as

Extracellular VesiclesLarvaStaining and LabelingZebrafishAnimalsCell-type specific EV imagingDevelopmentExtracellular vesicles (EVs)In vivo imagingSize exclusion chromatography (SEC)Tissue digestionZebrafish

Identifiers

PMID41088362
PMCPMC12522632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.